Effect of amikacin-humic acid combination on biofilm: an and study.

(AB) is a clinically important bacterial pathogen responsible for nosocomial infections. The biofilm-forming capability of these pathogens reduces the antibiotic penetration and its efficacy, thereby complicating the treatment. The current work aims to isolate the most potent biofilm-forming species from clinical isolates of the patient samples and to evaluate the efficacy of the amikacin-humic acid combination against it.